INTRODUCTION
Cocaine (COC) is powerful central nervous system stimulant. Chemically, it is an alkaloid of the tropane family, benzoylecgonine (BE) methyl ester. Although there are methods for its artificial synthesis, the major source of cocaine remains cultivated Coca (Erythroxylum coca and
Erythroxylum novogranatense).
Cocaine is one of the most popular drugs nowadays, being on par with opioids and amphetamines, and clearly outweighed by cannabis only. According to United Nations Office on Drugs and Crime (UNODC) statistic report, there were more than 18 million people affected worldwide as of 2016 [1] . For the same period, the number of people in Europe who have used cocaine is estimated to be more than 4 million (0.7% of population) [ibid.].
As cocaine is an illegal drug in most countries (in Bulgaria it falls under Group II of controlled substances, and more specifically, "Substances of high risk and limited medical use"), the detection of cocaine as well as its metabolites is an often task in analytical toxicology. However, due to its pharmacokinetic properties (short biological half-life of about 1 hour [2] and low excretion rate) cocaine itself is rarely detected in body fluids. Instead, its major metabolite, benzoylecgonine, is usually monitored, as its bioavailability is considerably longer (half-life of 5-6 hours [ibid.]). Cocaethylene, an active metabolite, which is the byproduct of concurrent consumption of cocaine and alcohol, is also of forensic importance. Chemical structures of these compounds are shown in From practical point of view, methods for cocaine determination in biological fluids could be separated into two groups: preliminary and confirmative. Preliminary methods are mostly based on immunoassay; they give express results (usually in order of minutes) and feature very good cut-off concentration levels (10-300 ng/mL) [3] [4] [5] [6] [7] . Such methods are of great importance to forensic work, e.g. crime scenes tests, workplace and driver tests, preliminary in-lab screenings, etc. However, due to low analytical specificity and non-zero risk of false positive / false negative results, a confirmative method for analysis is mandahttps://doi.org/10.5272/jimab.2017232.1523 tory in most cases [5] . As a gold standard for this purpose, a gas chromatography mass-spectrometry technique is widely accepted and reviewed [8, 9] . Some of GS-MS methods are focused on best sensitivity to achieve excellent results, although that complicates the procedure and increases the lab time. Others use simplified techniques in order to cut down the price and shorten the time consumption, however purification of the sample is inevitably sacrificed resulting in overloaded chromatograms and loss of selectivity. Hence, the main task of the current research is to find out and validate the most efficient approach by combining the advantages of already known studies and optimizing the procedure to best fit the needs of Laboratory of analytical toxicology in Naval Hospital -Varna for routine forensic expertise on daily basis.
MATHERIALS AND METHODS
All of the used chemical reagents were of analytical grade or better. The necessary solutions are prepared using HPLC grade solvents and purified deionized water (0.067-0.100 µS cm -1 , TKA™ Pacific water purification system). Certified reference material (Quick-Check™ Drug Solutions of 1 mg mL -1 COC in MeOH and 1 mg mL -1 BE in MeOH) were purchased from f Alltech Associates, Inc., USA.
SPE Phenomenex ® cartridges (Strata ® Screen-C, 55µm, 70Å, 150 mg/3mL tubes) were used. Human blood and plasma from controlled stationary patients of Naval Hospital -Varna, available in Clinical Laboratory, were taken at random and used for preparation of spiked samples.
GC-MS analysis was done on Agilent Technologies 7890B GC System & 5977A MSD module. Data acquisition and processing were controlled by Agilent MassHunter software package. Reference data from mass spectral library NIST version 2.0 g was used for comparison.
Statistical analysis was done using OriginPro ® software.
RESULTS AND DISCUSSION
Reference data Prior to analysis of biological matrices, reference GC-MS data were collected, using appropriately diluted standard cocaine and benzoylecgonine solutions. The general screening procedure used on daily basis in Laboratory was applied; analysis conditions are listed in Table 1 . All GC-MS parameters have been intentionally left unoptimized, as it has been proved inconvenient to switch software settings over and over again in an environment of frequent emergency.
Cocaine solution (1 µL 50 µg mL -1 in MeOH) was directly injected into GC column, yielding a clear, singlepeak chromatogram. Cocaine was identified at Rt = 25.62 min, mass spectrum (EI, 70 eV), m/z (Irel, %): 82 (100), 94 (41), 182 * (87), 198 (10), 303 (18). Qualifying ions are given in bold, first of which is routinely used for quantitation purposes. The result is in excellent agreement with both software NIST library and reference MS spectrum data [10] .
Benzoylecgonine was analyzed only after chemical derivatization by silylation. Two commercially available agents were used and compared: BSTFA (N,O-bis (trimethylsilyl) trifluoroacetamide + 1% TMCS (trimethylchlorosilane)) and MTBSTFA (N-methyl-N-tertbutyldimethylsilyltrifluoroacetamide + 1% TBDMCS (tertbutyldimethylchlorosilane)). Derivatization procedure included initial evaporation of aliquot BE solution (10 µL 100 µg mL -1 in MeOH) under gentle stream of nitrogen (at < 60 o C), reconstitution in 30 µL of ethyl acetate, addition of 50 µL silylation mixture and heating for 20 min at 70°C. After cooling, 1 µL of solution was injected into GC column, without evaporation. Using BSTFA a benzoylecgonine derivate BE × TMS was identified at Rt = 25.97 min, mass spectrum (EI, 70 eV), m/z (Irel, %): 82 (100), 105 (32), 240 * (39), 256 (6), 361 (12) . Using MTBSTFA a benzoylecgonine derivate BE × TBDMS was identified at Rt = 28.31 min, mass spectrum (EI, 70 eV), m/ z (Irel, %): 82 (100), 105 (32), 282 * (25), 346 (17), 403 (11) .
Other cocaine-related tropane-type substances had been occasionally identified in real blood samples as well. However, as analytical grade standards were not available at the time of the study, results given bellow should not be treated as reference data. 
Experimental procedure
Purification of biological matrices before GC-MS analysis was done by mean of solid-phase extraction using silica-based strong type cation exchanger. Procedure description follows:
(1) Condition the SPE column applying 2 mL MeOH followed by 2 mL water.
(2) Prepare the sample by diluting 1 mL blood serum/plasma with 2 mL of water, or by diluting 1 mL urine with 2 mL of 0.1 M phosphate buffer pH 6.0. Load the sample at rate as low as 1 drop per second.
(3) Wash the column consequently by 2 mL 0.1 M HCl and 2 mL MeOH.
(4) Dry at full vacuum for 2 minutes.
(5) Elute drop wise using 2 mL 5% ammonium hydroxide in MeOH.
(6) Thoroughly evaporate under nitrogen stream (at < 60 o C) to complete dryness.
If the explicit goal is cocaine identification, at this stage reconstitute the residue in 2-3 droplets of MeOH and inject 1 µL of solution into GC column. However, more often the benzoylecgonine is the primary target, and hence the procedure continues with derivatization steps. Note that cocaine (as well as cocaethylene) goes through derivatization unaffected and will be present in final chromatogram anyway. 
Method validation
Keeping in mind that COC/BE/CE confirmative GC-MS analysis is often used as a decision factor in criminal justice and forensic science, increased demands on results accuracy are applicable, according to Blackstone's law formulation. Declaring a sample positive is granted only after a rigorous set of acceptance criteria has been met. Strictly identical set of acceptance criteria were involved in procedure of LoD determination. Acceptance criteria were constructed a priori, applying unusually severe requirements, all of which to be simultaneously agreed:
(1) Rt of the sample signal differs less than 1% of the value, obtained from calibrating standard and qualifying ions ratios agree within ±20% relative to those obtained for a calibrating standard;
(2) Relative intensity of any qualifying ion at peak maximum exceeds mean background noise plus 3 standard deviations (p < 0.01).
(3) Positive NIST library identification of the substance.
Here, set (1) represents the strongly recommended empirical approach [11, 12] , while set (2) follows statistical approach. In order to achieve maximum reduction of type I (false positive) errors, we apply both.
Actual LoD determination was done by carefully preparing a set of spiked blood samples (at levels 400, 200, 100, 50, 25, 12.5 ng mL -1 ) for every substance of interest. Spiked samples underwent described analytical procedure. LoD was associated with the lowest analyte concentration at which all of the acceptance criteria are still agreed. For cocaine LoD was estimated to 50 ng mL -1 , for benzoylecgonine (derivatized by BSTFA) to 100 ng mL -1 , and for benzoylecgonine (derivatized by MTBSTFA) -to 25 ng mL -1 . The advantage of MTBSTFA over BSTFA silylation is obvious.
Due to the severe requirements accepted, presence of benzoylecgonine in test samples even at LoD levels was proven to produce clear evidence of well-defined peak area, as it is shown on Fig. 2 for example. 
CONCLUSION
After a critical consideration of available methods, an optimized approach to cocaine and its major metabolite identification in biological samples has been proposed. Validation of the method by means of certified analytical standards has proven it accurate and sensitive. It has been demonstrated that effectiveness of MTBSTFA as a derivatization agent is significantly greater than of BSTFA. The optimized analytical procedure is simple, relatively short (under 90 minutes), and needs maintaining routine set of reagents only (water, methanol, HCl, NH3). The main purpose of this optimized method is application in forensic expertise analysis.
